Cleidocranial dysplasia (CCD) is an autosomal dominant heritable skeletal disease caused by heterozygous mutations in the osteoblast-specific transcription factor RUNX2. We have performed mutational analysis of RUNX2 on 24 unrelated patients with CCD. In 17 patients, 16 distinct mutations were detected in the coding region of RUNX2: 4 frameshift, 3 nonsense, 6 missense, and 2 splicing mutations, in addition to 1 polymorphism. The missense mutations were all clustered within the Runt domain, and their protein products were severely impaired in DNA binding and transactivation. In contrast, two RUNX2 mutants had the Runt domain intact and remained partially competent for transactivation. One criterion of CCD, short stature, was much milder in ...
Cleidocranial dysplasia (CCD) is an inherited autosomal-dominant skeletal disease caused by heterozy...
Cleidocranial dysplasia (CCD) is an inherited autosomal-dominant skeletal disease caused by heterozy...
We report clinical and molecular findings in 14 patients with cleidocranial dysplasia (CCD), a well ...
Cleidocranial dysplasia (CCD) is an autosomal dominant heritable skeletal disease caused by heterozy...
Cleidocranial dysplasia (CCD) is a dominantly inherited skeletal dysplasia caused by mutations in th...
Cleidocranial dysplasia (CCD) is a dominantly inherited skeletal dysplasia caused by mutations in th...
Cleidocranial dysplasia (CCD) is a dominantly inherited skeletal dysplasia caused by mutations in th...
Cleidocranial dysplasia (CCD) is a autosomal dominant disorder characterized by skeletal anomalies s...
Abstract. Cleidocranial dysplasia (CCD) is an autosomal dominant inheritable skeletal disease caused...
Background: Cleidocranial dysplasia (CCD) is an autosomal dominant disease that affects the skeletal...
Runt-related transcription factor 2 (RUNX2/Cbfa1) is the main regulatory gene controlling skeletal d...
Cleidocranial dysplasia (CCD) is an autosomal dominant inheritable skeletal disorder characterized b...
Objective: Mutations in the RUNX2 gene, a master regulator of bone formation, have been identified i...
Objective: Mutations in the RUNX2 gene, a master regulator of bone formation, have been identified i...
Cleidocranial dysplasia (CCD) is a rare autosomal dominant skeletal disorder caused by mutation of r...
Cleidocranial dysplasia (CCD) is an inherited autosomal-dominant skeletal disease caused by heterozy...
Cleidocranial dysplasia (CCD) is an inherited autosomal-dominant skeletal disease caused by heterozy...
We report clinical and molecular findings in 14 patients with cleidocranial dysplasia (CCD), a well ...
Cleidocranial dysplasia (CCD) is an autosomal dominant heritable skeletal disease caused by heterozy...
Cleidocranial dysplasia (CCD) is a dominantly inherited skeletal dysplasia caused by mutations in th...
Cleidocranial dysplasia (CCD) is a dominantly inherited skeletal dysplasia caused by mutations in th...
Cleidocranial dysplasia (CCD) is a dominantly inherited skeletal dysplasia caused by mutations in th...
Cleidocranial dysplasia (CCD) is a autosomal dominant disorder characterized by skeletal anomalies s...
Abstract. Cleidocranial dysplasia (CCD) is an autosomal dominant inheritable skeletal disease caused...
Background: Cleidocranial dysplasia (CCD) is an autosomal dominant disease that affects the skeletal...
Runt-related transcription factor 2 (RUNX2/Cbfa1) is the main regulatory gene controlling skeletal d...
Cleidocranial dysplasia (CCD) is an autosomal dominant inheritable skeletal disorder characterized b...
Objective: Mutations in the RUNX2 gene, a master regulator of bone formation, have been identified i...
Objective: Mutations in the RUNX2 gene, a master regulator of bone formation, have been identified i...
Cleidocranial dysplasia (CCD) is a rare autosomal dominant skeletal disorder caused by mutation of r...
Cleidocranial dysplasia (CCD) is an inherited autosomal-dominant skeletal disease caused by heterozy...
Cleidocranial dysplasia (CCD) is an inherited autosomal-dominant skeletal disease caused by heterozy...
We report clinical and molecular findings in 14 patients with cleidocranial dysplasia (CCD), a well ...